New antibacterial drug, Vabomere, approved for treatment of complicated UTIs in adults
by Press Release from Outbreak News Today on (#30PK9)
The U.S. Food and Drug Administration Tuesday approved Vabomere for adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis, caused by specific bacteria. Vabomere is a drug containing meropenem, an antibacterial, and vaborbactam, which inhibits certain types of resistance mechanisms used by bacteria. "The FDA is committed to making new safe ["]
The post New antibacterial drug, Vabomere, approved for treatment of complicated UTIs in adults appeared first on Outbreak News Today.